Early Detection and Diagnosis

You have full text access to this OnlineOpen article

Prediction of metastasis from low-malignant breast cancer by gene expression profiling

  1. Mads Thomassen1,2,†,*,
  2. Qihua Tan1,2,3,
  3. Freyja Eiriksdottir1,2,
  4. Martin Bak4,
  5. Søren Cold5,
  6. Torben A. Kruse1,2

Article first published online: 27 NOV 2006

DOI: 10.1002/ijc.22449

Issue

International Journal of Cancer

International Journal of Cancer

Volume 120, Issue 5, pages 1070–1075, 1 March 2007

Additional Information

How to Cite

Thomassen, M., Tan, Q., Eiriksdottir, F., Bak, M., Cold, S. and Kruse, T. A. (2007), Prediction of metastasis from low-malignant breast cancer by gene expression profiling. Int. J. Cancer, 120: 1070–1075. doi: 10.1002/ijc.22449

Author Information

  1. 1

    Department of Biochemistry, Pharmacology, and Genetics, Odense University Hospital, Odense, Denmark

  2. 2

    Human Microarray Centre (HUMAC), University of Southern Denmark, Odense, Denmark

  3. 3

    Institute of Public Health, University of Southern Denmark, Odense, Denmark

  4. 4

    Department of Pathology, Odense University Hospital, Odense, Denmark

  5. 5

    Department of Oncology, Odense University Hospital, Odense, Denmark

  1. †

    Fax: +45-65411911.

*Department of Biochemistry, Pharmacology, and Genetics, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, Denmark

Publication History

  1. Issue published online: 19 JAN 2007
  2. Article first published online: 27 NOV 2006
  3. Manuscript Accepted: 5 OCT 2006
  4. Manuscript Received: 20 JUL 2006

Funded by

  • Clinical Institute and Regional Institute of Health Sciences Research
  • Raimond and Dagmar Ringgård Bohns Fond
  • Dagmar Marshalls fond
  • AP Møllers Fond til Lægevidenskabens Fremme
  • Fabrikant Einar Willumsens Mindelegat
  • Kurt Boennelyckes fond
  • Købmand Svend Hansens Fond
  • Else Poulsens Mindelegat
  • Bankdirektør Hans Stener og Hustru Agnes Steners legat
  • Danish Biotechnology Instrumentation Centre (DABIC)
  • Clinical Institute and Regional Institute of Health Sciences Research at University of Southern Denmark

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (204K)

References

  • 1
    van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530–6.
  • 2
    van de Vijver, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009.
  • 3
    Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365: 671–79.
  • 4
    Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 2005; 7: R953–R964.
  • 5
    Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357–65.
  • 6
    Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359–77.
  • 7
    Thomassen M, Skov V, Eiriksdottir F, Tan Q, Jochumsen K, Fritzner N, Brusgaard K, Dahlgaard J, Kruse TA. Spotting and validation of a genome wide oligonucleotide chip with duplicate measurement of each gene. Biochem Biophys Res Commun 2006; 344: 1111–20.
  • 8
    Huber W, von HA, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18 ( Suppl 1): S96–S104.
  • 9
    Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002; 99: 6567–72.
  • 10
    Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, Ares M,Jr, Haussler D. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA 2000; 97: 262–67.
  • 11
    Liu H, Li J, Wong L. A comparative study on feature selection and classification methods using gene expression profiles and proteomic patterns. Genome Inform 2002; 13: 51–60.
  • 12
    Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–21.
  • 13
    Hosack DA, Dennis G,Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
  • 14
    Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–50.
  • 15
    Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 2006; 7: 91.
  • 16
    Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003; 100: 15901–5.
  • 17
    Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33: 49–54.
  • 18
    Dai H, van't VL, Lamb J, He YD, Mao M, Fine BM, Bernards R, van d Vijver, Deutsch P, Sachs A, Stoughton R, Friend S. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res 2005; 65: 4059–66.
  • 19
    Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de RM, Brown PO, et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005; 102: 3738–3743.
  • 20
    Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004; 6: R149–R156.
  • 21
    Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, Chew KL, Dairkee SH, Jensen RM, Waldman FM. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 2003; 63: 7167–75.
  • 22
    Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardly A, et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005; 353: 2747–57.
  • 23
    Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer 2006; 6: 99–106.
  • 24
    Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101: 9309–14.
  • 25
    Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006; 98: 262–72.
View Full Article with Supporting Information (HTML) Get PDF (204K)